The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and Nine months ended on December 31, 2025 along with Limited Review Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab Limited's Board has approved the Q3 FY26 and 9-month FY26 standalone unaudited financial results for the period ended December 31, 2025. Revenue from operations for Q3 stood at Rs 2,514.09 lakhs, down about 20.7% from Rs 3,168.94 lakhs in Q3 FY25, while 9-month revenue grew modestly to Rs 8,445.23 lakhs (vs Rs 8,184.99 lakhs YoY). Profit after tax jumped sharply to Rs 57.01 lakhs in Q3 (vs Rs 29.98 lakhs) and Rs 271.39 lakhs for 9M FY26 (vs Rs 199.91 lakhs), translating to 9M basic EPS of Rs 1.85. The Limited Review Report by Shah Kailash & Associates LLP was clean with no qualifications or adverse remarks. The company operates in a single segment (manufacturing and trading of grey cloth) and reported no pending investor complaints during the period.
Mixed picture: sharp Q3 revenue decline is a concern, but strong profit growth suggests improved margins or lower costs. Clean audit report is reassuring, though shareholders should watch whether revenue recovery sustains in Q4 FY26.